185 related articles for article (PubMed ID: 25300222)
21. Lipoprotein Subfractions and Glucose Homeostasis in Prediabetes and Diabetes in Taiwan.
Hsu H; Hsu P; Cheng MH; Ito Y; Kanda E; Schaefer EJ; Ai M
J Atheroscler Thromb; 2019 Oct; 26(10):890-914. PubMed ID: 30726792
[TBL] [Abstract][Full Text] [Related]
22. Independent association of severity of obstructive sleep apnea with lipid metabolism of atherogenic index of plasma (AIP) and apoB/apoAI ratio.
Cao B; Fan Z; Zhang Y; Li T
Sleep Breath; 2020 Dec; 24(4):1507-1513. PubMed ID: 31981042
[TBL] [Abstract][Full Text] [Related]
23. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS
Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691
[TBL] [Abstract][Full Text] [Related]
24. Treatment with PCSK9 inhibitors reduces atherogenic VLDL remnants in a real-world study.
Hollstein T; Vogt A; Grenkowitz T; Stojakovic T; März W; Laufs U; Bölükbasi B; Steinhagen-Thiessen E; Scharnagl H; Kassner U
Vascul Pharmacol; 2019 May; 116():8-15. PubMed ID: 30910670
[TBL] [Abstract][Full Text] [Related]
25. Effects of atorvastatin 10 mg and fenofibrate 200 mg on the low-density lipoprotein profile in dyslipidemic patients: A 12-week, multicenter, randomized, open-label, parallel-group study.
Ansquer JC; Corda C; Le Malicot K; Jessent V
Curr Ther Res Clin Exp; 2009 Apr; 70(2):71-93. PubMed ID: 24683220
[TBL] [Abstract][Full Text] [Related]
26. Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis.
Siddiqui MS; Sterling RK; Luketic VA; Puri P; Stravitz RT; Bouneva I; Boyett S; Fuchs M; Sargeant C; Warnick GR; Grami S; Sanyal AJ
Gastroenterology; 2013 Dec; 145(6):1271-9.e1-3. PubMed ID: 23973920
[TBL] [Abstract][Full Text] [Related]
27. Metabolic Properties of Lowdensity Lipoprotein (LDL) Triglycerides in Patients with Type 2 Diabetes, Comparison with Small Dense LDL-Cholesterol.
Hirano T; Kodera R; Hirashima T; Suzuki N; Aoki E; Hosoya M; Oshima T; Hayashi T; Koba S; Ohta M; Satoh N; Ito Y
J Atheroscler Thromb; 2022 May; 29(5):762-774. PubMed ID: 33952832
[TBL] [Abstract][Full Text] [Related]
28. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
[TBL] [Abstract][Full Text] [Related]
29. Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man.
Muls E; Rosseneu M; Bury J; Stul M; Lamberigts G; De Moor P
J Clin Endocrinol Metab; 1985 Nov; 61(5):882-9. PubMed ID: 3930554
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
[TBL] [Abstract][Full Text] [Related]
31. Changes in the distribution and composition of high-density lipoproteins in primary hypothyroidism.
Muls E; Rosseneu M; Lamberigts G; De Moor P
Metabolism; 1985 Apr; 34(4):345-53. PubMed ID: 3920475
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of the LDL-C/apoB ratio in the overall evaluation of atherogenicity of lipid profile.
Kaneva AM; Potolitsyna NN; Bojko ER
Arch Physiol Biochem; 2017 Feb; 123(1):16-22. PubMed ID: 27347637
[TBL] [Abstract][Full Text] [Related]
33. Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON.
Lorenzatti AJ; Monsalvo ML; López JAG; Wang H; Rosenson RS
Cardiovasc Diabetol; 2021 Apr; 20(1):94. PubMed ID: 33941192
[TBL] [Abstract][Full Text] [Related]
34. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
35. Discordance between lipoprotein (a) and LDL-cholesterol levels in cardiovascular risk assessment in apparently healthy subjects.
Bergmann K; Stefanska A; Krintus M; Sypniewska G
Nutr Metab Cardiovasc Dis; 2023 Jul; 33(7):1429-1436. PubMed ID: 37169665
[TBL] [Abstract][Full Text] [Related]
36. Improvement of blood inflammatory marker levels in patients with hypothyroidism under levothyroxine treatment.
Marchiori RC; Pereira LA; Naujorks AA; Rovaris DL; Meinerz DF; Duarte MM; Rocha JB
BMC Endocr Disord; 2015 Jun; 15():32. PubMed ID: 26100072
[TBL] [Abstract][Full Text] [Related]
37. Non-fasting lipids detection and their significance in pregnant women.
Li Y; He J; Zeng X; Zhao S; Wang X; Yuan H
Lipids Health Dis; 2019 Apr; 18(1):96. PubMed ID: 30975209
[TBL] [Abstract][Full Text] [Related]
38. Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors.
Dansinger ML; Williams PT; Superko HR; Schaefer EJ
Lipids Health Dis; 2019 Jul; 18(1):154. PubMed ID: 31311555
[TBL] [Abstract][Full Text] [Related]
39. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.
Guérin M; Le Goff W; Lassel TS; Van Tol A; Steiner G; Chapman MJ
Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):282-8. PubMed ID: 11156866
[TBL] [Abstract][Full Text] [Related]
40. Non-HDL Cholesterol is a More Superior Predictor of Small-Dense LDL Cholesterol than LDL Cholesterol in Japanese Subjects with TG Levels ＜400 mg/dL.
Moriyama K; Takahashi E
J Atheroscler Thromb; 2016 Sep; 23(9):1126-37. PubMed ID: 27001003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
